| Literature DB >> 35402729 |
Frank Watson Sinyiza1, Master R O Chisale2, Alfred B Kayira3, Chikondi Sharon Chimbatata4, Paul Uchizi Kaseka4, Pocha Kamudumuli5, Tsung-Shu Joseph Wu6, Balwani Chingatichifwe Mbakaya7.
Abstract
Objective: Orbito-ocular cancers are a common cause of morbidity and mortality in our population, yet these cancers have not been adequately described in Malawi. This study sought to describe the burden and histopathological profile of orbito-ocular cancers in Northern Malawi. Methods and Analysis: A retrospective review of pathology reports was done. Descriptive analyses were performed to summarise patients' demographic and clinical characteristics, and histopathological results. A binary logistic regression was used to explore the association between demographic variables, site of lesion and cancer.Entities:
Keywords: conjunctiva; neoplasia; ocular surface; orbit; pathology
Mesh:
Year: 2022 PMID: 35402729 PMCID: PMC8948413 DOI: 10.1136/bmjophth-2022-000977
Source DB: PubMed Journal: BMJ Open Ophthalmol ISSN: 2397-3269
Figure 1Processes involved in specimen processing at KCH/UNC laboratory. KCH/UNC, Kamuzu Central Hospital/University of North Carolina.
Demographic characteristics of patients and histology findings of the biopsies analysed
| Variable | Frequency (%) | |
| Sex | Female | 126 (60.0) |
| Male | 84 (40.0) | |
| Age (years) | 0–10 | 22 (10.5) |
| 11–20 | 9 (4.3) | |
| 21–30 | 38 (18.1) | |
| 31–40 | 64 (30.5) | |
| 41–50 | 48 (22.9) | |
| 51–60 | 18 (8.6) | |
| 61–70 | 6 (2.9) | |
| >70 | 2 (1.0) | |
| Missing | 3 (1.4) | |
| HIV status | Negative | 48 (22.9) |
| Positive | 37 (17.6) | |
| Unknown/undocumented | 125 (59.5) | |
| Site of biopsy | Eyelid/adnexa | 28 (13.3) |
| Conjunctiva | 134 (63.8) | |
| Intraocular | 25 (11.9) | |
| Unspecified | 23 (10.9) | |
| Histology findings | Cancer | 84 (40.0) |
| No cancer | 126 (60.0) | |
| Histological types of cancer (n=84) | Squamous cell carcinoma | 69 (82.1) |
| Retinoblastoma | 6 (7.1) | |
| Kaposi sarcoma | 2 (2.4) | |
| Small B cell lymphoma | 1 (1.2) | |
| Other invasive carcinomas | 6 (7.1) | |
Mean age—34.81±15.9 years, range: 4 months to 91 years.
Association between orbito-ocular cancers and demographic variables and site of lesion
| Variable | Cancer (%) | No cancer (%) | Unadjusted OR (95% CI)* | Adjusted OR (95% CI)† | |
| Sex | Female | 45 (35.7) | 81 (64.3) | – | – |
| Male | 39 (46.4) | 45 (53.6) | 1.6 (0.8 to 2.7) | 1.5 (0.7 to 2.8) | |
| Age (years) | 0–10 (reference) | 10 (45.5) | 12 (54.5) | – | – |
| 11–20 | 1 (11.1) | 8 (88.9) | 0.2 (0.0 to 1.4) | 0.2 (0.0 to 2.2) | |
| 21–30 | 10 (26.3) | 28 (73.7) | 0.4 (0.1 to 1.3) | 0.7 (0.2 to 2.7) | |
| 31–40 | 29 (45.3) | 35 (54.7) | 1.0 (0.4 to 2.6) | 1.5 (0.4 to 5.3) | |
| 41–50 | 27 (56.3) | 21 (43.7) | 1.5 (0.6 to 4.3) | 1.9 (0.5 to 6.7) | |
| 51–60 | 4 (22.2) | 14 (77.8) | 0.3 (0.1 to 1.4) | 0.3 (0.1 to 1.6) | |
| 61–70 | 1 (16.7) | 5 (83.3) | 0.2 (0.0 to 2.4) | 0.7 (0.1 to 7.8) | |
| >70 | 1 (50.0) | 1 (50.0) | 1.2 (0.1 to 21.7) | 1.1 (0.0 to 39. 9) | |
| HIV status | Negative (reference) | 11 (22.9) | 37 (78.1) | – | – |
| Positive | 25 (67.6) | 12 (32.4) | 7.0 (2.7 to 18.4) | 5.9 (2.0 to 17.2) | |
| Unknown | 48 (38.4) | 77 (61.6) | 2.1 (0.9 to 4.5) | 1.9 (0.8 to 4.6) | |
| Site | Eye lid/adnexa (reference) | 6 (21.4) | 22 (78.6) | – | – |
| Conjunctiva | 54 (40.3) | 80 (59.7) | 2.5 (0.9 to 6.5) | 1.9 (0.6 to 5.4) | |
| Intraocular | 18 (72.0) | 7 (28.0) | 9.4 (2.7 to 33.1) | 8.3 (2.0 to 33.8) | |
| Not specified | 6 (26.1) | 17 (73.9) | 1.3 (0.4 to 4.7) | 0.7 (0.2 to 2.9) | |
*Univariable binary logistic regression.
†Multivariable binary logistic regression, adjusting for all other variables in the table.
Stratified analysis of type of cancer by demographic characteristics and site of lesion
| Demographic variables | Type of cancer | ||||||
| Squamous cell carcinoma (%) | Retinoblastoma (%) | Kaposi sarcoma (%) | Small B cell lymphoma (%) | Other invasive carcinomas (%) | Total (%) | ||
| Sex | Female | 36 (80.0) | 3 (6.7)) | 1 (2.2) | 1 (2.2) | 4 (8.9) | 45 (100) |
| Male | 33 (84.6) | 3 (7.7) | 1 (2.6) | 0 (0.0) | 2 (5.1) | 39 (100) | |
| Age (years) | 0–10 | 4 (40.0) | 5 (50.0) | 1 (10.0) | 0 (0.0) | 0 (0.0) | 10 (100) |
| 11–20 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100) | 1 (100) | |
| 21–30 | 9 (90.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (10.0) | 10 (100) | |
| 31–40 | 25 (86.2) | 0 (0.0) | 1 (3.5) | 0 (0.0) | 3 (10.3) | 29 (100) | |
| 41–50 | 26 (96.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (3.7) | 27 (100) | |
| 51–60 | 3 (75.0) | 0 (0.0) | 0 (0.0) | 1 (25.0)) | 0 (0.0) | 4 (100) | |
| 61–70 | 1 (100) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100) | |
| >70 | 1 (100) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (100) | |
| HIV status | Negative | 9 (81.8) | 1 (9.1) | 0 (0.0) | 1 (9.1) | 0 (0.0) | 11 (100) |
| Positive | 25 (100) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 25 (100) | |
| Unknown | 35 (72.9) | 5 (10.4) | 2 (4.2) | 0 (0.0) | 6 (12.5) | 48 (100) | |
| Site of lesion | Eye lid/adnexa | 4 (66.7) | 0 (0.0) | 1 (16.7) | 1 (16.7) | 0 (0.0) | 6 (100) |
| Conjunctiva | 51 (94.4) | 0 (0.0) | 1 (1.9) | 0 (0.0) | 2 (3.7) | 54 (100) | |
| Intraocular | 10 (55.6) | 5 (27.8) | 0 (0.0) | 0 (0.0) | 3 (16.7) | 18 (00) | |
| Not specified | 4 (66.7) | 1 (16.70 | 0 (0.0) | 0 (0.0) | 1 (16.7) | 6 (100) | |